IL127959A0 - Variants of human ciliary neurotrophic factor (hcntf) with a range of action different from that of the wild-type molecule - Google Patents

Variants of human ciliary neurotrophic factor (hcntf) with a range of action different from that of the wild-type molecule

Info

Publication number
IL127959A0
IL127959A0 IL12795997A IL12795997A IL127959A0 IL 127959 A0 IL127959 A0 IL 127959A0 IL 12795997 A IL12795997 A IL 12795997A IL 12795997 A IL12795997 A IL 12795997A IL 127959 A0 IL127959 A0 IL 127959A0
Authority
IL
Israel
Prior art keywords
variants
hcntf
wild
range
neurotrophic factor
Prior art date
Application number
IL12795997A
Other languages
English (en)
Original Assignee
Angeletti P Ist Richerche Bio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeletti P Ist Richerche Bio filed Critical Angeletti P Ist Richerche Bio
Publication of IL127959A0 publication Critical patent/IL127959A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
IL12795997A 1996-07-10 1997-07-10 Variants of human ciliary neurotrophic factor (hcntf) with a range of action different from that of the wild-type molecule IL127959A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96RM000492A IT1284867B1 (it) 1996-07-10 1996-07-10 Varianti del fattore neurotrofico ciliare umano (hcntf) con uno spettro di azione differente dalla molecola di tipo selvatico
PCT/IT1997/000163 WO1998001149A2 (fr) 1996-07-10 1997-07-10 VARIANTS DE FACTEUR NEUROTROPHIQUE CILIAIRE HUMAIN (hCNTF) AYANT UN CHAMP D'ACTION DIFFERENT DE CELUI DE LA MOLECULE DE TYPE SAUVAGE

Publications (1)

Publication Number Publication Date
IL127959A0 true IL127959A0 (en) 1999-11-30

Family

ID=11404333

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12795997A IL127959A0 (en) 1996-07-10 1997-07-10 Variants of human ciliary neurotrophic factor (hcntf) with a range of action different from that of the wild-type molecule

Country Status (11)

Country Link
US (1) US6756357B1 (fr)
EP (1) EP0936919B1 (fr)
JP (1) JP3329826B2 (fr)
AT (1) ATE331734T1 (fr)
AU (1) AU719086B2 (fr)
CA (1) CA2260296C (fr)
DE (1) DE69736241T2 (fr)
ES (1) ES2265653T3 (fr)
IL (1) IL127959A0 (fr)
IT (1) IT1284867B1 (fr)
WO (1) WO1998001149A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1288388B1 (it) * 1996-11-19 1998-09-22 Angeletti P Ist Richerche Bio Uso di sostanze che attivano il recettore del cntf ( fattore neurotrofico ciliare) per la preparazione di farmaci per la terapia
IT1291114B1 (it) * 1997-03-20 1998-12-29 Angeletti P Ist Richerche Bio Varianti del fattore neurotrofico ciliare (cntf) con migliorata selettivita' al recettore, e metodo per la loro selezione
AU2017370653B2 (en) * 2016-12-06 2022-07-21 The Board Of Trustees Of The Leland Stanford Junior University Ciliary neurotrophic factor receptor ligand-binding agents and methods of using the same
US11179441B2 (en) 2017-01-06 2021-11-23 The Board Of Trustees Of The Leland Stanford Junior University Ciliary neurotrophic factor receptor ligands and methods of using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5349056A (en) 1992-10-09 1994-09-20 Regeneron Pharmaceuticals Modified ciliary neurotrophic factors
US5939534A (en) * 1993-12-29 1999-08-17 Sumitomo Pharmaceuticals Company, Limited Factors mutated in the D1 cap region
GB9413316D0 (en) 1994-07-01 1994-08-24 Cancer Res Campaign Tech Novel proteins

Also Published As

Publication number Publication date
DE69736241T2 (de) 2007-05-31
AU719086B2 (en) 2000-05-04
ATE331734T1 (de) 2006-07-15
JP3329826B2 (ja) 2002-09-30
WO1998001149A3 (fr) 1998-04-23
AU3557697A (en) 1998-02-02
ITRM960492A1 (it) 1998-01-10
US6756357B1 (en) 2004-06-29
JP2000507271A (ja) 2000-06-13
EP0936919B1 (fr) 2006-06-28
ITRM960492A0 (fr) 1996-07-10
WO1998001149A2 (fr) 1998-01-15
CA2260296A1 (fr) 1998-01-15
DE69736241D1 (de) 2006-08-10
CA2260296C (fr) 2006-05-16
IT1284867B1 (it) 1998-05-22
EP0936919A2 (fr) 1999-08-25
ES2265653T3 (es) 2007-02-16

Similar Documents

Publication Publication Date Title
AU2424597A (en) Methods for diagnosing and treating alzheimer's disease
IL185763A0 (en) Peptides that lower blood glucose levels
DE69839014D1 (de) Apolipoprotein a-i agonisten und deren verwendung zur behandlung dyslipidämischer erkrankungen
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
MY132189A (en) Recombinant obese (ob) proteins
IL121790A0 (en) Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor (GDNF) protein product
ATE212359T1 (de) Neurotrophe peptide des aktivitätsabhängigen neurotrophen faktors
DE59811158D1 (de) Verwendung von erythropoietin und eisenpräparaten zur herstellung von pharmazeutischen kombinationspräparaten zur behandlung von rheumatischen erkrankungen
ES2133329T3 (es) Variantes de il-3 humana.
PT851762E (pt) Preparacoes farmaceuticas de combinacao contendo eritropoietina e preparacoes de ferro
IL127959A0 (en) Variants of human ciliary neurotrophic factor (hcntf) with a range of action different from that of the wild-type molecule
NO931413L (no) Fremgangsmaater og preparater for behandling av celleproliferasjonssykdommer
EP0716591A4 (fr) PROCEDES ET COMPOSITIONS DESTINES A FIXER DES PROTEINES TAU ET MAP2c
HU9202075D0 (en) Bcrf1 proteins of gamma-interferon inhibiting effect
DE69534633D1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
HU9202092D0 (en) An implantate composition containing biologically active protein, peptide or polypeptide
ATE151774T1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
PT782630E (pt) Gene da doenca poliquistica do rim
ATE345809T1 (de) Arzneimittelzusammensetzung enthaltend tcf-ii
DE69829995D1 (de) Multivalente rekombinante antikörper zur behandlung von hrv infektionen
DE69633172D1 (en) Ndf-peptide
ATE235249T1 (de) Die von morphogenen peptiden hervorgerufene wiederherstellung von gewebe aus sinneszellen
DE59611330D1 (de) Arzneimittel enthaltend wenigstens einen teil des ul84-proteins des cytomegalovirus, verwendung von polypeptiden entsprechend der aminosäuresequenz des ul84-proteins und verfahren zur einführung von ul84 in zielzellen
IT1251961B (it) Peptidi che rappresentano permutazioni della sequenza del mastoparano
Lindblad et al. Presenilin-1 in neuroblastoma cells